EFDID: 471578EFD: View Filing

Issuer: OS THERAPIES Inc (0001795091) - D

Accession: 0001795091-23-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001795091
  • Entity Name:
    OS THERAPIES Inc
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2018)
  • Address:
    15825 Shady Grove Road
    Suite 135
    Rockville, MD 20850
  • Persons:
    Related Persons 8
    Paul Romness
    Executive Officer, Director 
    President and Chief Executive Officer
    Christopher Acevedo
    Executive Officer 
    Chief Financial Officer
    Robert Petit
    Executive Officer 
    Chief Scientific Officer and Chief Medical Officer
    Jutta Wanner
    Executive Officer 
    Chief Technology Officer
    Colin Goddard
    Director
    Joacim Borg
    Director
    John Ciccio
    Director
    Theodore Search
    Director
EDGAR: Offering Information
  • Accession Date:
    01/10/2023
  • First Sale Date:
    11/16/2022
  • Offering Amount:
    $2,000,000
  • Amount Sold:
    $2,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Convertible promissory notes including underlying Class A common stock issuable upon conversion of such notes.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Noble Capital Markets, Inc. 15768 None None All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
OS THERAPIES Inc/s/ Paul RomnessPaul RomnessPresident and Chief Executive Officer2023-01-10